BIOLASE (BIOL) Competitors

NanoVibronix (NASDAQ:NAOV) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

Which has more volatility and risk, NAOV or BIOL?

NanoVibronix has a beta of 1.5, indicating that its stock price is 50% more volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.

Is NAOV or BIOL more profitable?

BIOLASE has a net margin of -41.65% compared to NanoVibronix's net margin of -83.49%. NanoVibronix's return on equity of -74.98% beat BIOLASE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NanoVibronix	-83.49%	-74.98%	-43.38%
BIOLASE	-41.65%	-1,782.73%	-55.31%

Which has stronger earnings and valuation, NAOV or BIOL?

NanoVibronix has higher earnings, but lower revenue than BIOLASE. NanoVibronix is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NanoVibronix	$3.37M	0.48	-$3.71M	-$1.69	-0.35
BIOLASE	$48.83M	0.01	-$20.63M	-$14.94	0.00

Do analysts rate NAOV or BIOL?

BIOLASE has a consensus target price of $1.20, suggesting a potential upside of 9,577.42%. Given BIOLASE's higher possible upside, analysts plainly believe BIOLASE is more favorable than NanoVibronix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NanoVibronix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
BIOLASE	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Does the media refer more to NAOV or BIOL?

In the previous week, NanoVibronix had 3 more articles in the media than BIOLASE. MarketBeat recorded 6 mentions for NanoVibronix and 3 mentions for BIOLASE. NanoVibronix's average media sentiment score of 0.90 beat BIOLASE's score of 0.57 indicating that NanoVibronix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NanoVibronix	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BIOLASE	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals believe in NAOV or BIOL?

16.4% of NanoVibronix shares are held by institutional investors. Comparatively, 8.8% of BIOLASE shares are held by institutional investors. 3.6% of NanoVibronix shares are held by insiders. Comparatively, 0.3% of BIOLASE shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer NAOV or BIOL?

BIOLASE received 221 more outperform votes than NanoVibronix when rated by MarketBeat users. However, 57.26% of users gave NanoVibronix an outperform vote while only 53.58% of users gave BIOLASE an outperform vote.

Company	Underperform	Outperform
NanoVibronix	Outperform Votes 71 57.26%	Underperform Votes 53 42.74%
BIOLASE	Outperform Votes 292 53.58%	Underperform Votes 253 46.42%

Summary

NanoVibronix beats BIOLASE on 11 of the 17 factors compared between the two stocks.